ARTV
Artiva BiotherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ARTV vs peer average
27/100
ARTV vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
NKTX is the first available peer comparator.
NK cell-focused developer with earlier clinical validation; comparable tech focus and partnership potential.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ARTV
Artiva Biotherapeutics
NKTX
Nkarta
Grade
F
D
Momentum
84
57
Value
41
41
Sentiment
0
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs NKTX
ARTV / NKTX
Grade Position
Below peers
ARTV vs. peer average (F vs. D)
27/100
Momentum
84
ARTVValue
41
ARTVSentiment
0
NKTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ARTV
NKTX is the first peer returned for this comparison set.